Predictors of recurrent arteriovenous fistula stenosis in Saudi patients undergoing hemodialysis

References

1. 1.↵
   1. Hill NR,
   2. Fatoba ST,
   3. Oke JL,
   4. Hirst JA,
   5. O’Callaghan CA, et al.

   Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PloS One 12016; 11: e0158765.
2. 2.↵
   1. Levey AS,
   2. Coresh J,
   3. Balk E,
   4. Kausz AT,
   5. Levin A,
   6. Steffes MW, et al.

   National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Bylsma LC,
   2. Gage SM,
   3. Reichert H,
   4. Dahl SLM,
   5. Lawson JH.

   Arteriovenous fistulae for haemodialysis: a systematic review and meta-analysis of efficacy and safety outcomes. Eur J Vasc Endovasc Surg 2017; 54: 513-522.

   OpenUrlPubMed
4. 4.↵
   1. Michael S,
   2. Qaja E.

   Types of Arteriovenous Fistulas. Treasure Island (FL): StatPearls Publishing; 2022.
5. 5.↵
   1. Lok CE,
   2. Huber TS,
   3. Lee T,
   4. Shenoy S,
   5. Yevzlin AS,
   6. Abreo K, et al.

   KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis 2020; 75: S1-S164.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Campos RP,
   2. Do Nascimento MM,
   3. Chula DC,
   4. Do Nascimento DE,
   5. Riellal MC.

   Stenosis in hemodialysis arteriovenous fistula: evaluation and treatment. Hemodial Int 2006; 10: 152-161.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Neves M,
   2. Outerelo C,
   3. Pereira M,
   4. Neves F,
   5. Carvalho T,
   6. Maia P, et al.

   Predictive factors of recurrent endovascular intervention for cephalic arch stenosis after percutaneous transluminal angioplasty. J Vasc Surg 2018; 68: 836-842.

   OpenUrl
8. 8.↵
   1. Al-Sayyari AA,
   2. Shaheen FA.

   End stage chronic kidney disease in Saudi Arabia. A rapidly changing scene. Saudi Med J 2011; 32: 339-346.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Mousa D,
   2. Alharbi A,
   3. Helal I,
   4. Al-Homrany M,
   5. Alhujaili F,
   6. Alhweish A,
   7. Marie MA,
   8. Al Sayyari A.

   Prevalence and associated factors of chronic kidney disease among relatives of hemodialysis patients in Saudi Arabia. Kidney Int Rep 2021; 6: 817-820.

   OpenUrl
10. 10.↵
    1. Neuen BL,
    2. Gunnarsson R,
    3. Webster AC,
    4. Baer RA,
    5. Golledge J,
    6. Mantha ML.

    Predictors of patency after balloon angioplasty in hemodialysis fistulas: a systematic review. J Vasc Interv Radiol 2014; 25: 917-924.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Wu J,
    2. Xie J,
    3. Zhao Y,
    4. Gong LI,
    5. Liu X,
    6. Liu W.

    Serum calcium is related to the degree of artery stenosis in acute ischemic stroke.” Cell Physiol Biochem 2018; 46: 1189-1197.

    OpenUrl
12. 12.
    1. Rasouli M,
    2. Kiasari AM.

    Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo) lipoproteins. Clin Chem Lab Med 2006; 44: 43-50.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Etemadi J,
    2. Rahbar K,
    3. Haghighi AN,
    4. Bagheri N,
    5. Falaknazi K,
    6. Ardalan MR, et al.

    Renal artery stenosis in kidney transplants: assessment of the risk factors. Vascular health and risk management 2011; 7: 503-507.

    OpenUrl
14. 14.↵
    1. Kats M,
    2. Hawxby AM,
    3. Barker J,
    4. Allon M.

    Impact of obesity on arteriovenous fistula outcomes in dialysis patients. Kidney Int 2007; 71: 39-43.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Distefano G,
    2. Zanoli L,
    3. Basile A,
    4. Fatuzzo P,
    5. Granata A.

    Arteriovenous fistula and pre-surgery mapping: Potential role of physical exercise on endothelial function. J Vasc Access 2019; 20: 652-658.

    OpenUrl
16. 16.↵
    1. Troisi N,
    2. Frosini P,
    3. Somma C,
    4. Romano E,
    5. Guidotti A,
    6. Dattolo PC, et al.

    Drug-coated balloons reduce the risk of recurrent restenosis in arteriovenous fistulas and prosthetic grafts for hemodialysis. Int Angiol 2017; 37: 59-63.

    OpenUrl
17. 17.↵
    1. Hsu YH,
    2. Yen YC,
    3. Lin YC,
    4. Sung LC.

    Antiplatelet agents maintain arteriovenous fistula and graft function in patients receiving hemodialysis: A nationwide case-control study. PloS One 2018; 13: e0206011.

    OpenUrl
18. 18.↵
    1. Murley A,
    2. Wijewardane A,
    3. Wilmink T,
    4. Baharan J.

    Should patients be on antithrombotic medication for their first arteriovenous fistulae?. J Vasc Access 2016; 17: 118-123.

    OpenUrl
19. 19.↵
    1. Kaufman JS,
    2. O’Connor TZ,
    3. Zhang JH,
    4. Cronin RE,
    5. Fiore LD,
    6. Ganz MB, et al.

    Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol 2003; 14: 2313-2321.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Heine GH,
    2. Ulrich C,
    3. Köhler H,
    4. Girndt M.

    Is AV fistula patency associated with angiotensin-converting enzyme (ACE) polymorphism and ACE inhibitor intake? Am J Nephrol 2004; 24: 461-468.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Aktas A,
    2. Bozkurt A,
    3. Aktas B,
    4. Kirbas I.

    Percutaneous transluminal balloon angioplasty in stenosis of native hemodialysis arteriovenous fistulas: technical success and analysis of factors affecting postprocedural fistula patency. Diagn Interv Radiol 2015; 21: 160-166.

    OpenUrlPubMed